CA1045136A - Thiazole derivatives - Google Patents
Thiazole derivativesInfo
- Publication number
- CA1045136A CA1045136A CA213,282A CA213282A CA1045136A CA 1045136 A CA1045136 A CA 1045136A CA 213282 A CA213282 A CA 213282A CA 1045136 A CA1045136 A CA 1045136A
- Authority
- CA
- Canada
- Prior art keywords
- hydrogen
- formula
- lower alkyl
- thiazole
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000007979 thiazole derivatives Chemical class 0.000 title claims abstract description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 26
- 239000001257 hydrogen Substances 0.000 claims abstract description 26
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 25
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 14
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 11
- 150000002367 halogens Chemical group 0.000 claims abstract description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 5
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims description 24
- -1 cyano, phenyl Chemical group 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 14
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims description 13
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 12
- 150000001412 amines Chemical class 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000004442 acylamino group Chemical group 0.000 claims description 6
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 6
- 125000001544 thienyl group Chemical group 0.000 claims description 5
- 125000002541 furyl group Chemical group 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 125000000168 pyrrolyl group Chemical group 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 3
- 125000000335 thiazolyl group Chemical group 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 229910001873 dinitrogen Inorganic materials 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 7
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- 150000003944 halohydrins Chemical class 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 abstract description 16
- 230000000903 blocking effect Effects 0.000 abstract description 6
- 125000000753 cycloalkyl group Chemical group 0.000 abstract description 5
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 5
- 229910052760 oxygen Inorganic materials 0.000 abstract description 5
- 125000003107 substituted aryl group Chemical group 0.000 abstract description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 4
- 239000001301 oxygen Substances 0.000 abstract description 4
- 150000003839 salts Chemical class 0.000 abstract description 4
- 229910052717 sulfur Inorganic materials 0.000 abstract description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract description 3
- 231100000053 low toxicity Toxicity 0.000 abstract description 3
- 239000011593 sulfur Substances 0.000 abstract description 3
- 206010002383 Angina Pectoris Diseases 0.000 abstract description 2
- 206010003119 arrhythmia Diseases 0.000 abstract description 2
- 230000006793 arrhythmia Effects 0.000 abstract description 2
- 208000029078 coronary artery disease Diseases 0.000 abstract description 2
- 208000019622 heart disease Diseases 0.000 abstract description 2
- 230000000144 pharmacologic effect Effects 0.000 abstract description 2
- 230000003449 preventive effect Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 50
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 39
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 20
- 239000000243 solution Substances 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 229940022682 acetone Drugs 0.000 description 12
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 12
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000002585 base Substances 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- OCVLSHAVSIYKLI-UHFFFAOYSA-N 3h-1,3-thiazole-2-thione Chemical class SC1=NC=CS1 OCVLSHAVSIYKLI-UHFFFAOYSA-N 0.000 description 5
- 239000012458 free base Substances 0.000 description 5
- 229960003712 propranolol Drugs 0.000 description 5
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 5
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 102000005962 receptors Human genes 0.000 description 4
- 108020003175 receptors Proteins 0.000 description 4
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 3
- ORECNKBJIMKZNX-UHFFFAOYSA-N 1,3-thiazol-3-ium;chloride Chemical compound Cl.C1=CSC=N1 ORECNKBJIMKZNX-UHFFFAOYSA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- DURULFYMVIFBIR-UHFFFAOYSA-N practolol Chemical compound CC(C)NCC(O)COC1=CC=C(NC(C)=O)C=C1 DURULFYMVIFBIR-UHFFFAOYSA-N 0.000 description 3
- 229960001749 practolol Drugs 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 230000007059 acute toxicity Effects 0.000 description 2
- 231100000403 acute toxicity Toxicity 0.000 description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000005283 haloketone group Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- HPOKESDSMZRZLC-UHFFFAOYSA-N propan-2-one;hydrochloride Chemical compound Cl.CC(C)=O HPOKESDSMZRZLC-UHFFFAOYSA-N 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000008279 sol Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229930192474 thiophene Natural products 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- KEEKMOIRJUWKNK-CABZTGNLSA-N (2S)-2-[[2-[(4R)-4-(difluoromethyl)-2-oxo-1,3-thiazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide Chemical compound FC([C@H]1N(C(SC1)=O)C=1N=C2N(CCOC3=C2C=CC(=C3)N[C@H](C(=O)N)C)C=1)F KEEKMOIRJUWKNK-CABZTGNLSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- XOKIPANBKVPEEZ-UHFFFAOYSA-N 2-chloro-1-(1-methylpyrrol-2-yl)ethanone Chemical compound CN1C=CC=C1C(=O)CCl XOKIPANBKVPEEZ-UHFFFAOYSA-N 0.000 description 1
- ZQXSFZAMFNRZOQ-UHFFFAOYSA-N 2-methylpropan-2-ol;hydrate Chemical compound O.CC(C)(C)O ZQXSFZAMFNRZOQ-UHFFFAOYSA-N 0.000 description 1
- WYKHSBAVLOPISI-UHFFFAOYSA-N 2-phenyl-1,3-thiazole Chemical compound C1=CSC(C=2C=CC=CC=2)=N1 WYKHSBAVLOPISI-UHFFFAOYSA-N 0.000 description 1
- KXCQDIWJQBSUJF-UHFFFAOYSA-N 4-phenyl-1,3-thiazole Chemical compound S1C=NC(C=2C=CC=CC=2)=C1 KXCQDIWJQBSUJF-UHFFFAOYSA-N 0.000 description 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 1
- CCIKQTPISUSOEB-UHFFFAOYSA-N 6-ethyl-3h-thieno[2,3-d]pyrimidine-4-thione Chemical compound S1C(CC)=CC2=C1N=CNC2=S CCIKQTPISUSOEB-UHFFFAOYSA-N 0.000 description 1
- 108060003345 Adrenergic Receptor Proteins 0.000 description 1
- 102000017910 Adrenergic receptor Human genes 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- GBENHPGBEDXMIW-UHFFFAOYSA-N N.[Na+].[K+] Chemical group N.[Na+].[K+] GBENHPGBEDXMIW-UHFFFAOYSA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000534944 Thia Species 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 description 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- YNNGZCVDIREDDK-UHFFFAOYSA-N aminocarbamodithioic acid Chemical compound NNC(S)=S YNNGZCVDIREDDK-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- DKVNPHBNOWQYFE-UHFFFAOYSA-N carbamodithioic acid Chemical class NC(S)=S DKVNPHBNOWQYFE-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- XTEGARKTQYYJKE-UHFFFAOYSA-N chloric acid Chemical compound OCl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-N 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- 229960004926 chlorobutanol Drugs 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 230000002057 chronotropic effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000003001 depressive effect Effects 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- YIBPLYRWHCQZEB-UHFFFAOYSA-N formaldehyde;propan-2-one Chemical compound O=C.CC(C)=O YIBPLYRWHCQZEB-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 230000001534 intropic effect Effects 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 125000000842 isoxazolyl group Chemical group 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229940075930 picrate Drugs 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 description 1
- 125000005936 piperidyl group Chemical group 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- KIDBBTHHMJOMAU-UHFFFAOYSA-N propan-1-ol;hydrate Chemical compound O.CCCO KIDBBTHHMJOMAU-UHFFFAOYSA-N 0.000 description 1
- XTUSEBKMEQERQV-UHFFFAOYSA-N propan-2-ol;hydrate Chemical compound O.CC(C)O XTUSEBKMEQERQV-UHFFFAOYSA-N 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000001226 reprecipitation Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
ABSTRACT OF THE DISCLOSURE
Novel thiazole derivatives of the formula (I);
(I) wherein R1 and R2 are each hydrogen, lower alkyl, cycloalkyl, optionally substituted aryl or optionally substituted hetero-aromatic ring containing any one or more of oxygen, sulfur, or nitrogen, and R3 and R4 are each hydrogen or lower alkyl, and salts thereof, may be prepared by reacting a thiazole derivative of the formula (II) (II) wherein R1 and R2 have the same meanings as defined above and A is or
Novel thiazole derivatives of the formula (I);
(I) wherein R1 and R2 are each hydrogen, lower alkyl, cycloalkyl, optionally substituted aryl or optionally substituted hetero-aromatic ring containing any one or more of oxygen, sulfur, or nitrogen, and R3 and R4 are each hydrogen or lower alkyl, and salts thereof, may be prepared by reacting a thiazole derivative of the formula (II) (II) wherein R1 and R2 have the same meanings as defined above and A is or
Description
~04513~ -This invention relates to a process ~or producing novel thiazole de~ivatives of the formula (I);
R2 ~ ~
S SCH2C~cH2NR3R4 ~ .
wherein Rl and R2 are each hydrogen, lower alkyl, cycloalkyl, optionally substituted aryl or optionally substituted hetero- :
aromatic ring containing any one or more of oxygen~ sulfur, .
or nitrogen, and R3 and R4 are each hydrogen or lower alkyl,and salts thereof, and the invention also relates to the production ~.
thereofO , ;, . .
The term, "lower alkyl" as used herein includes C - C ~ ::
alkyl (for example, methyl, ethyl, n-propyl, iso-propylg n- ~ :
butyl, iso-butyl, t-butyl); methyl,ethyl, iso~propyl and t-butyl ~.
are preferredO
The term "optionally substituted aryl" as used herein ..
includes phenyl, substituted phenyl, naphthyl and substituted ~ `
':, ..
naphthyl with the substituents being Cl - C4 alkyl (for example, ~ ;
. methyl, ethyl, n~propyl, iso-propyl, n-butylg iso-butyl, sec- : .
butyl, t-butyl), C1 - C4 alkoxy (for example, m~thoxy, ethoxy, n-propoxy, iso-propoxy, n-butoxy, iso--butoxy, t-butoxy), hydroxyl, C3 -~C5 alkenyl (for example, propenyl, butenyl, hexenyl), , C3 - C5 alkenyloxy (for example,~propenyloxy, butenyloxy, - `:
hexenyloxy), halogeno (for example, iodo, chloro, bromo, 1uoro), cyano, aminoj nitro, aryloxy (for example, phenoxy, naphthoxy) ~ and acylamino (or example, acetamido, propionamido, benzamido)0 : ~ ~The term "cycloalkyl" includes C3 - C6 cycloakyls, among ~-~ which cyclohexyl is preferred;
:;~ ''" ~ ~'.'' ::
- ~45~3~
h~ teIm ~optionally substituted heteroaromatic ring"
includes 5 and 6 membered rings containing any one or more of oxygen, sul~ur, or nitrogen and rings formed by the condensation of these with benzene rings, preferably furyl, thienyl, pyrrolyl, thiazolyl, iso-thiazoLyl, imidazolyl, pyra~olyl, oxazolylJ
isoxazolyl, pyridyl, pyrLmidinyl, pyrazinyl, benzothienyl~
benzoLmidazolyl, indolyl, and qui.nolylO Among these, furyl, thienyl, thiazolyl, pyrrolyl, pyridyl are most preferred. As the substitutents of these heteroaromatic rings, there may be exemplified lower alkyl, lower alkoxy, halogen, amino~ nitro, cyano, phenyl, acylamino, groups of the formula . .
-- C -- Y
(wherein Y is hydroxy, lower alkyl, lower alkoxy or lower ~ :
alkenyloxy) and groups of the formula ..
- C - N - R ~:~
(wherein R5 and R6 are each hydrogen, amino, lower alkyl, cyclo- : ;.
alkyl, optionally substituted aryl and, when taken together with ; :.
20 adjacent nitrogen, may form a heterocyclic group). In the above :
the term "acylamino" may include C2 - C8 acylamino, (for example, - acetamido, propionamido, benzamide), and the.term "lower alkenyl- . . :
~ . .,: .
loxyl' includes C3 - C5 alkenyloxy (for example, propenyloxy, butenyloxy, hexenyloxy~, and the term "cycloalkyl" include~ .
C3 ~ & cycloalkyl wherein cyclopropyl, cyclopentyl and cyclohexyl are preferred, and the term "heterocyclic groups" includes 5 and ..
6 membered heterocyclic groups, in which morpholinyl, pyrrolidinyl, piperidyl and thiomorpholinyl are preferred. The other terms "lower alkyl", "lower alkoxy", "halogen" and "optionally .
: .
1C~45136 substituted aryl" hav~ the same meanings as aboveO
A principal object of the present invention is to provide .
a process for preparing novel thiazole derivatives of the formula (I).
.i .
The thiazole derivatives of the formula (I) hav~ excellent pharmacological properties, such as ~-adrenergic receptor blocking effect, with low toxicity, and are valuable compounds exerting preventive or therapeutic effect on heart diseases, for example, arrhythmia, angina pectoris and other coronary heart disease In order to show these properties of ~-adrenergic receptor , blocking activity and low toxicity, thiazole derivatives of the formula (I) are compared with propranolol and practolol, which are commercially available compounds, and are known as two of ~;
the most effective compounds in the field of this inventionO As can be seen from the following Tables, thiazole derivatives of the formula (I) have stronger or the same ~-adrenerglc receptor blocking activity but less toxi.city than propranolol and practolol .:
TabIe Compound ~-adrenergic receptor blocking .
: 20 activity in open chest dog : .
- (propranolol = 1~
DPC DPI DDE .~ ;:
:: compd O of Example 22 2 1~5 4 ;` compd. of :
. -: Example 37 : 15 15 8 - compdO of ~ ~I Example 35 2 3 oO 8 ; ~ ~
`~ ~Propranolol 1 l l ~ ` :
, . .~ -~Practolol 0~5 0O7 oO
Note: The determination of ~~adrenergic receptor blocking , activity of the test compounds in open chest dogs ~as as follows. .:
. ~ 3 ~ .:~
' ': ' -~04513~
- The dogs were anesthetized with pentbarbital sodium (ad-ministrated 30 - 40 my./kg. intraveneously). Heart rate, myocardial contractile force and blood pressure were recorded with NIHON KODEN RM-150* polygraph. The depressive effect of test compounds on positive chronotropic (DPC), positive : intropic (DPI) and depresser effect (DDE) induced by :~ .
isoproterenol injected intraveneously at a quarter hour ~' intervals~ was determinedO :
Table 2 Acute toxicity Compound Acute toxicity ~:
LD50 (mg./k compdO of Example 22 46 compd. of Example 37 86 . : .
compd. of Example 35 60 Propranolol 23 .
Note: For the determination of the intraveneous LD50, 10 male mice were used, and the method of up and down was used for .:
calculation of the LD50.
According to the present invention, the thiazole derlvatlves of the formula (I) : ', Rl ~ OH . (I) : : 2CHFE2~R3R4 :., ~ . :
`~ ~ *Trade Mark ~ 4 -~lO4~S~L36 wherein Rl~ R2, R3 and R4 have the same meanings as defined before, are prepared by reacting a thiazole dexivative of the formula (II) ' R2 ~ ~ (II) ~
.. " ',, wherein Rl and R2 have the same meanings as defined above and ~
A is R
_ CH2CHCH2 or ~
- C ~ ~HCH2X
where X is a halogen, with an amine of the formula (III) .
j H~R3R4 (III) wherein R3 and Rl~ have the same meanings as defined above. ~.
More particularly, the thiazole derivatives of the formula :~;
(I) are prepared by reacting a thiazole derivative of the formula (~I) wlth an amine of the formula (III) in a sealed tube by .~ ~:
heating to a temperature of from 30~co to 150~C~, or by heating ,.. ~
to a temperature of from 30~C. to 150C. in the presence of an : :
organic solvent (-for example, methanol, ethanol, n-propanol, iso~
: . . :
propanol, n-butanol, iso-butanol, sec-butanol, t-butanol~ dio~ane, : dimethyl formamide, dimethyl acetamlde, dimethylsulfoxide, acetone), or a water-organic solvent system (for example, water-methanol~
water-ethanol, water-n-propanol, water-iso-propanol, water~n~
.,: :.:
butanol, water-iso-butanol, water-sec-butanol, water-t-butanol)0 ..
It is preferred to carry out the reaction under reflux in an~alcoholic solution. The reaction can be carried out using a .::
- 5 - :
:. :, ,, , -- --~045136 mixture of the compound of the formula (IIa)O
-S ~ (IIa) ` S - CH2 - C~-&H2 O '.
wherein Rl and R2 are each as defined above, and the compound of the formula (Ilb), R N
R2 ~ ~
S SCH2C~cH2NR3R4 ~ .
wherein Rl and R2 are each hydrogen, lower alkyl, cycloalkyl, optionally substituted aryl or optionally substituted hetero- :
aromatic ring containing any one or more of oxygen~ sulfur, .
or nitrogen, and R3 and R4 are each hydrogen or lower alkyl,and salts thereof, and the invention also relates to the production ~.
thereofO , ;, . .
The term, "lower alkyl" as used herein includes C - C ~ ::
alkyl (for example, methyl, ethyl, n-propyl, iso-propylg n- ~ :
butyl, iso-butyl, t-butyl); methyl,ethyl, iso~propyl and t-butyl ~.
are preferredO
The term "optionally substituted aryl" as used herein ..
includes phenyl, substituted phenyl, naphthyl and substituted ~ `
':, ..
naphthyl with the substituents being Cl - C4 alkyl (for example, ~ ;
. methyl, ethyl, n~propyl, iso-propyl, n-butylg iso-butyl, sec- : .
butyl, t-butyl), C1 - C4 alkoxy (for example, m~thoxy, ethoxy, n-propoxy, iso-propoxy, n-butoxy, iso--butoxy, t-butoxy), hydroxyl, C3 -~C5 alkenyl (for example, propenyl, butenyl, hexenyl), , C3 - C5 alkenyloxy (for example,~propenyloxy, butenyloxy, - `:
hexenyloxy), halogeno (for example, iodo, chloro, bromo, 1uoro), cyano, aminoj nitro, aryloxy (for example, phenoxy, naphthoxy) ~ and acylamino (or example, acetamido, propionamido, benzamido)0 : ~ ~The term "cycloalkyl" includes C3 - C6 cycloakyls, among ~-~ which cyclohexyl is preferred;
:;~ ''" ~ ~'.'' ::
- ~45~3~
h~ teIm ~optionally substituted heteroaromatic ring"
includes 5 and 6 membered rings containing any one or more of oxygen, sul~ur, or nitrogen and rings formed by the condensation of these with benzene rings, preferably furyl, thienyl, pyrrolyl, thiazolyl, iso-thiazoLyl, imidazolyl, pyra~olyl, oxazolylJ
isoxazolyl, pyridyl, pyrLmidinyl, pyrazinyl, benzothienyl~
benzoLmidazolyl, indolyl, and qui.nolylO Among these, furyl, thienyl, thiazolyl, pyrrolyl, pyridyl are most preferred. As the substitutents of these heteroaromatic rings, there may be exemplified lower alkyl, lower alkoxy, halogen, amino~ nitro, cyano, phenyl, acylamino, groups of the formula . .
-- C -- Y
(wherein Y is hydroxy, lower alkyl, lower alkoxy or lower ~ :
alkenyloxy) and groups of the formula ..
- C - N - R ~:~
(wherein R5 and R6 are each hydrogen, amino, lower alkyl, cyclo- : ;.
alkyl, optionally substituted aryl and, when taken together with ; :.
20 adjacent nitrogen, may form a heterocyclic group). In the above :
the term "acylamino" may include C2 - C8 acylamino, (for example, - acetamido, propionamido, benzamide), and the.term "lower alkenyl- . . :
~ . .,: .
loxyl' includes C3 - C5 alkenyloxy (for example, propenyloxy, butenyloxy, hexenyloxy~, and the term "cycloalkyl" include~ .
C3 ~ & cycloalkyl wherein cyclopropyl, cyclopentyl and cyclohexyl are preferred, and the term "heterocyclic groups" includes 5 and ..
6 membered heterocyclic groups, in which morpholinyl, pyrrolidinyl, piperidyl and thiomorpholinyl are preferred. The other terms "lower alkyl", "lower alkoxy", "halogen" and "optionally .
: .
1C~45136 substituted aryl" hav~ the same meanings as aboveO
A principal object of the present invention is to provide .
a process for preparing novel thiazole derivatives of the formula (I).
.i .
The thiazole derivatives of the formula (I) hav~ excellent pharmacological properties, such as ~-adrenergic receptor blocking effect, with low toxicity, and are valuable compounds exerting preventive or therapeutic effect on heart diseases, for example, arrhythmia, angina pectoris and other coronary heart disease In order to show these properties of ~-adrenergic receptor , blocking activity and low toxicity, thiazole derivatives of the formula (I) are compared with propranolol and practolol, which are commercially available compounds, and are known as two of ~;
the most effective compounds in the field of this inventionO As can be seen from the following Tables, thiazole derivatives of the formula (I) have stronger or the same ~-adrenerglc receptor blocking activity but less toxi.city than propranolol and practolol .:
TabIe Compound ~-adrenergic receptor blocking .
: 20 activity in open chest dog : .
- (propranolol = 1~
DPC DPI DDE .~ ;:
:: compd O of Example 22 2 1~5 4 ;` compd. of :
. -: Example 37 : 15 15 8 - compdO of ~ ~I Example 35 2 3 oO 8 ; ~ ~
`~ ~Propranolol 1 l l ~ ` :
, . .~ -~Practolol 0~5 0O7 oO
Note: The determination of ~~adrenergic receptor blocking , activity of the test compounds in open chest dogs ~as as follows. .:
. ~ 3 ~ .:~
' ': ' -~04513~
- The dogs were anesthetized with pentbarbital sodium (ad-ministrated 30 - 40 my./kg. intraveneously). Heart rate, myocardial contractile force and blood pressure were recorded with NIHON KODEN RM-150* polygraph. The depressive effect of test compounds on positive chronotropic (DPC), positive : intropic (DPI) and depresser effect (DDE) induced by :~ .
isoproterenol injected intraveneously at a quarter hour ~' intervals~ was determinedO :
Table 2 Acute toxicity Compound Acute toxicity ~:
LD50 (mg./k compdO of Example 22 46 compd. of Example 37 86 . : .
compd. of Example 35 60 Propranolol 23 .
Note: For the determination of the intraveneous LD50, 10 male mice were used, and the method of up and down was used for .:
calculation of the LD50.
According to the present invention, the thiazole derlvatlves of the formula (I) : ', Rl ~ OH . (I) : : 2CHFE2~R3R4 :., ~ . :
`~ ~ *Trade Mark ~ 4 -~lO4~S~L36 wherein Rl~ R2, R3 and R4 have the same meanings as defined before, are prepared by reacting a thiazole dexivative of the formula (II) ' R2 ~ ~ (II) ~
.. " ',, wherein Rl and R2 have the same meanings as defined above and ~
A is R
_ CH2CHCH2 or ~
- C ~ ~HCH2X
where X is a halogen, with an amine of the formula (III) .
j H~R3R4 (III) wherein R3 and Rl~ have the same meanings as defined above. ~.
More particularly, the thiazole derivatives of the formula :~;
(I) are prepared by reacting a thiazole derivative of the formula (~I) wlth an amine of the formula (III) in a sealed tube by .~ ~:
heating to a temperature of from 30~co to 150~C~, or by heating ,.. ~
to a temperature of from 30~C. to 150C. in the presence of an : :
organic solvent (-for example, methanol, ethanol, n-propanol, iso~
: . . :
propanol, n-butanol, iso-butanol, sec-butanol, t-butanol~ dio~ane, : dimethyl formamide, dimethyl acetamlde, dimethylsulfoxide, acetone), or a water-organic solvent system (for example, water-methanol~
water-ethanol, water-n-propanol, water-iso-propanol, water~n~
.,: :.:
butanol, water-iso-butanol, water-sec-butanol, water-t-butanol)0 ..
It is preferred to carry out the reaction under reflux in an~alcoholic solution. The reaction can be carried out using a .::
- 5 - :
:. :, ,, , -- --~045136 mixture of the compound of the formula (IIa)O
-S ~ (IIa) ` S - CH2 - C~-&H2 O '.
wherein Rl and R2 are each as defined above, and the compound of the formula (Ilb), R N
2 ~ S 1 f (IIb) 0~ . . '' :'-:
wherein Rl, R2 and X are each as defined aboveO .
However, the method of reacting an halohydxin derivative (IIb) 10 with an amine (III) is rather advantageous for commerci.al pro- . .
duction of the thiazoie derivative (I) than that of rea~ting a propoxide derivative (IIa) with an amine (III), because several ! ~
of the latter reactions produce some polymerized products in some cases. And, in order to prevent production of a by-product, ~ :
for example a pol~nerlzation produot, this reaction is preferably carried out in a nitrogen gas atmosphereO
:~ The reaction can preferably be conducted by using an .
excess~ amount of the amine of the formula (III) defined above, but it ~can also be carried out by using the amine (III) in amount j-.
subatantially equivalent to the compound of the ~ormula (II). ~ : :
, Thiazole derivatives thus obtained and salts thereo~ can : ~ .
:~ be isolated and refined by conven!tional procedures such as ex- ~ ::
. .
traotion, recrystallization, reprecipitation, column chromatography or treatment with active carbon, and can be converted to their pharmaceutically acceptable salts with inorganic or oxganic acid - ~04S136 ~ :
(for example, hydrochloric acid, sulfuric acid~ phosphoric acid, tartaric acid, mandelic acid, citric acid) according to con~
ventional procedures.
: 2-(2',3'-epoxypropylthio)-thiazole derivatives (IIa) and 2-(3'-choro-2'-hydroxypropylthio)-thiazole derivatives (IIb) :
can be prepared by reacting 2-mercaptothiazole derivatives (IV), :-wherein Rl and ~2 are defined above, with epichlorohydrin (V) in the presence of a base. ~; .-'. .
- O :. :
R r~ 2CHcH2 ~
....
Rl R ~ ; :
I . . p 1 11 OH l:
R2 1 ~ 5 ~ ~ SCH2CHCH2 2 ~ S ~ ~ SCH21HCH2Cl ... .
: (IIa) (Ilb) .;. .~:
: .
: ~ ~ In this case, 2-mercaptothiazole derivatives (IV) can be prepared by reacting a haloketone of the formula (VI) ~ ..
~ RlCOCHY
~ R2 (VI) ; ~ whexein Rl and R2 have the same.meanings as mentioned above, and ~ Y i8 halogen, with dithiocarbc~mic acid derivatives of the formula .
. ,: - ..
: (VII) H NCSR ; ~ (VII) wherein R6 is preferably sodium potassium ammonium, lower- ~`.:/
~: ~; alkyl and acyl group~ at a temperature of from -lO^C~ to 140C. - :.
,: . . : :
~ in the presence oL water or an organic solvent (for example, - 7 ~
.~ .
~LS~.3~
: alcohol, hydrocarbon, ether, ethyl acetate, tetxahydrofuran, and dioxane)0 It is preferred to add haloketone (VI) to dithiocarbamic acid derivatives under cooling and complete the reaction under reflux because most of this reaction is exothermicO
Among these intermediate compounds of the for~ula (IV)~
2-mercaptothiazole derivatives of the formula (VIII) .
~8 ~ S 1 SH (VIII) '~
wherein R7 is nitro, acylamino, cyano~ lower alkylamino- .
- carbonyl, lower alkoxycarbonyl, lower alkylcarbonyl,or hydrazino-carbonyl and R8 is hydrogen, cyano, or lower alkylaminocarbonyl ~ ~ :
and X is oxygen, sulfur~ or nitrogen atom, are newO
Alternatively, its carbamoyl derivatives (VIIIa) (~7 or R8 = carbamoyl) and its carboxy dexivatives (VIIIb) -(R7 or R8 = carboxy) are also obtained in high yield by hydrolysis of its cyano derivatives (VIIIc) (~ or R8 = cyano)0 ';,':
' ~, ' ' .' ";
,:
: . :
' -:
~ -., . ~ .
: lO~S136 .
H _ C ~ N H2NCC F~
S ~ SH X ~ S ~ SH
(VIIIc) \ (VIIIa) ~;
\ 3 x OH
HOOC ~ X = O, ~ orS) S SH ~ :
(~IIIb) And additionally, carboxy derivatives (VIIIb) .
(R7 or R8 = c~rboxy) are also prepared in high yield by : `
- hydrblysis of ester derivatives (VIIld) (R7 or R8 - alkoxy- : -carbonyl).
,. t . ~:
ROOC t~ / 1~ . ~ .~.. r . . .. ... -S SH acid or base ::
(VIIId) ~ ~ -HOOC ~ N ` .
X ~ ~ = N, O or S) ` ~ ;
S SH . : :
: (VIIIb) : . i ~.
~: ': . ~ . - . ,.; . ' ~ In order to illustxate the invention ih details, :~ - the following E~amples are given,but not by way of limita- :-~ ~ tlon. ~ `' ' .. .. .
xample 1 ~;`
2-(3'-t-but~lamino-2'-hydroxypropylthio)-4- .: .:
: phenyl thiazole hy~rochloride :
A solution of 1.25 g. o~ 2-(2',3'-epoxypropylthio)~
4-phenyl thiazole and lO~ml. of t-butylamine in 20 ml. o~ ~ .
~:~ methanol was refluxed ~or 4.6 hours~ ~fter the reaction ~vas ;:' ~ :........... ' ~ ' ' "' 1~)4S~36 over, the reactlon solution wa~ evaporated in vacuo to ~ive an oil, which was dissolved in chloroform and the chloroform solution was extracted with hydrochloric acid ' solution. ~he aqueous layer was made alkaline with 10 N ~;
aqueous so'dium hydroæiae solution and extracted with chloroform. " "'~
, ~he chloroform extract was aried over anhydrous magnesium sul~a~e and evaporated in vacuo to give an oil, ' ~ ,~
which was converted to its hydrochloride.
The hydrochloride was recrys-tallized from a ', ~' mixture of acetone and methanol to yield 2-(3'-t-butyl-amino-2'-hydroxypropylthio)-4-phenyl thiazole hydrochloride: , white solid, m.pO 169 - 174C;~ 0.7 g. ~ ' ' ~ound: C9 48.~4; H, 6.15; N, 6.83; S, 15.11, Cl, 17.00(%) ~ ;, C16H220N2S2~2HCl require~ C, 48.~8; H, 6.o6; N, 7.07; ~ ~
S, 16~16; Cl, 18.43 (%) ~ ',''~' 2-(2',7'-epoxypropylthio)-4-phenyl thiazole used as starting ma-terial wa~ prepared by the following~method desoribed below.
- ~
Four grc~m~ of 2-mercapto-4-phenyl thia'zoleJ 2.0 g.
of piperidine and 20 ml. of epichlorohydrin were mixed ~elow ' and heated at 8CC.~for 1 hour. APter cooling, the vola~
tile material wa~ removed in ~acuo, and the residue was dis- ~' solved in chloro~orm. ~he solutlon was washed with N a~ueou~
sodium hydroxide solution, dried~over anhydrou~ magnesium sulfate and evaporated under reduced pressure to give 7.22 g.
.:. ~ , . . .
~o~ an oil, which was purified~by column chromatography on silica gel to yield 2-(2',3'-epoxypropylthio)-4-phenyl ' ', ~'~ thiazole; colourle~s oil, n24 6 1.5678. ' ;; ~ ' , ~ ' Aocording to the method o~ Example 1, the following , ~ ..
10 ~ `' ''' ' ~ ', ' , .' ~... .
~ . ., , , " . , .~ ...... , . ., . , - . . .
1~5136 . :
compounds were prepared.
.
2 ~ S l SCH2C~2~IC - CH
C~3 -~ . .
Ex. R isolated NoO 1 R2 ~orm physical const. . .
..... _ ... .. _ . . . ~ . .
H hydro- m.p. 169-74a. ~:
chloride (acetone-methanol) 2 CH ~ hydro- m~p. 205-6C. -
wherein Rl, R2 and X are each as defined aboveO .
However, the method of reacting an halohydxin derivative (IIb) 10 with an amine (III) is rather advantageous for commerci.al pro- . .
duction of the thiazoie derivative (I) than that of rea~ting a propoxide derivative (IIa) with an amine (III), because several ! ~
of the latter reactions produce some polymerized products in some cases. And, in order to prevent production of a by-product, ~ :
for example a pol~nerlzation produot, this reaction is preferably carried out in a nitrogen gas atmosphereO
:~ The reaction can preferably be conducted by using an .
excess~ amount of the amine of the formula (III) defined above, but it ~can also be carried out by using the amine (III) in amount j-.
subatantially equivalent to the compound of the ~ormula (II). ~ : :
, Thiazole derivatives thus obtained and salts thereo~ can : ~ .
:~ be isolated and refined by conven!tional procedures such as ex- ~ ::
. .
traotion, recrystallization, reprecipitation, column chromatography or treatment with active carbon, and can be converted to their pharmaceutically acceptable salts with inorganic or oxganic acid - ~04S136 ~ :
(for example, hydrochloric acid, sulfuric acid~ phosphoric acid, tartaric acid, mandelic acid, citric acid) according to con~
ventional procedures.
: 2-(2',3'-epoxypropylthio)-thiazole derivatives (IIa) and 2-(3'-choro-2'-hydroxypropylthio)-thiazole derivatives (IIb) :
can be prepared by reacting 2-mercaptothiazole derivatives (IV), :-wherein Rl and ~2 are defined above, with epichlorohydrin (V) in the presence of a base. ~; .-'. .
- O :. :
R r~ 2CHcH2 ~
....
Rl R ~ ; :
I . . p 1 11 OH l:
R2 1 ~ 5 ~ ~ SCH2CHCH2 2 ~ S ~ ~ SCH21HCH2Cl ... .
: (IIa) (Ilb) .;. .~:
: .
: ~ ~ In this case, 2-mercaptothiazole derivatives (IV) can be prepared by reacting a haloketone of the formula (VI) ~ ..
~ RlCOCHY
~ R2 (VI) ; ~ whexein Rl and R2 have the same.meanings as mentioned above, and ~ Y i8 halogen, with dithiocarbc~mic acid derivatives of the formula .
. ,: - ..
: (VII) H NCSR ; ~ (VII) wherein R6 is preferably sodium potassium ammonium, lower- ~`.:/
~: ~; alkyl and acyl group~ at a temperature of from -lO^C~ to 140C. - :.
,: . . : :
~ in the presence oL water or an organic solvent (for example, - 7 ~
.~ .
~LS~.3~
: alcohol, hydrocarbon, ether, ethyl acetate, tetxahydrofuran, and dioxane)0 It is preferred to add haloketone (VI) to dithiocarbamic acid derivatives under cooling and complete the reaction under reflux because most of this reaction is exothermicO
Among these intermediate compounds of the for~ula (IV)~
2-mercaptothiazole derivatives of the formula (VIII) .
~8 ~ S 1 SH (VIII) '~
wherein R7 is nitro, acylamino, cyano~ lower alkylamino- .
- carbonyl, lower alkoxycarbonyl, lower alkylcarbonyl,or hydrazino-carbonyl and R8 is hydrogen, cyano, or lower alkylaminocarbonyl ~ ~ :
and X is oxygen, sulfur~ or nitrogen atom, are newO
Alternatively, its carbamoyl derivatives (VIIIa) (~7 or R8 = carbamoyl) and its carboxy dexivatives (VIIIb) -(R7 or R8 = carboxy) are also obtained in high yield by hydrolysis of its cyano derivatives (VIIIc) (~ or R8 = cyano)0 ';,':
' ~, ' ' .' ";
,:
: . :
' -:
~ -., . ~ .
: lO~S136 .
H _ C ~ N H2NCC F~
S ~ SH X ~ S ~ SH
(VIIIc) \ (VIIIa) ~;
\ 3 x OH
HOOC ~ X = O, ~ orS) S SH ~ :
(~IIIb) And additionally, carboxy derivatives (VIIIb) .
(R7 or R8 = c~rboxy) are also prepared in high yield by : `
- hydrblysis of ester derivatives (VIIld) (R7 or R8 - alkoxy- : -carbonyl).
,. t . ~:
ROOC t~ / 1~ . ~ .~.. r . . .. ... -S SH acid or base ::
(VIIId) ~ ~ -HOOC ~ N ` .
X ~ ~ = N, O or S) ` ~ ;
S SH . : :
: (VIIIb) : . i ~.
~: ': . ~ . - . ,.; . ' ~ In order to illustxate the invention ih details, :~ - the following E~amples are given,but not by way of limita- :-~ ~ tlon. ~ `' ' .. .. .
xample 1 ~;`
2-(3'-t-but~lamino-2'-hydroxypropylthio)-4- .: .:
: phenyl thiazole hy~rochloride :
A solution of 1.25 g. o~ 2-(2',3'-epoxypropylthio)~
4-phenyl thiazole and lO~ml. of t-butylamine in 20 ml. o~ ~ .
~:~ methanol was refluxed ~or 4.6 hours~ ~fter the reaction ~vas ;:' ~ :........... ' ~ ' ' "' 1~)4S~36 over, the reactlon solution wa~ evaporated in vacuo to ~ive an oil, which was dissolved in chloroform and the chloroform solution was extracted with hydrochloric acid ' solution. ~he aqueous layer was made alkaline with 10 N ~;
aqueous so'dium hydroæiae solution and extracted with chloroform. " "'~
, ~he chloroform extract was aried over anhydrous magnesium sul~a~e and evaporated in vacuo to give an oil, ' ~ ,~
which was converted to its hydrochloride.
The hydrochloride was recrys-tallized from a ', ~' mixture of acetone and methanol to yield 2-(3'-t-butyl-amino-2'-hydroxypropylthio)-4-phenyl thiazole hydrochloride: , white solid, m.pO 169 - 174C;~ 0.7 g. ~ ' ' ~ound: C9 48.~4; H, 6.15; N, 6.83; S, 15.11, Cl, 17.00(%) ~ ;, C16H220N2S2~2HCl require~ C, 48.~8; H, 6.o6; N, 7.07; ~ ~
S, 16~16; Cl, 18.43 (%) ~ ',''~' 2-(2',7'-epoxypropylthio)-4-phenyl thiazole used as starting ma-terial wa~ prepared by the following~method desoribed below.
- ~
Four grc~m~ of 2-mercapto-4-phenyl thia'zoleJ 2.0 g.
of piperidine and 20 ml. of epichlorohydrin were mixed ~elow ' and heated at 8CC.~for 1 hour. APter cooling, the vola~
tile material wa~ removed in ~acuo, and the residue was dis- ~' solved in chloro~orm. ~he solutlon was washed with N a~ueou~
sodium hydroxide solution, dried~over anhydrou~ magnesium sulfate and evaporated under reduced pressure to give 7.22 g.
.:. ~ , . . .
~o~ an oil, which was purified~by column chromatography on silica gel to yield 2-(2',3'-epoxypropylthio)-4-phenyl ' ', ~'~ thiazole; colourle~s oil, n24 6 1.5678. ' ;; ~ ' , ~ ' Aocording to the method o~ Example 1, the following , ~ ..
10 ~ `' ''' ' ~ ', ' , .' ~... .
~ . ., , , " . , .~ ...... , . ., . , - . . .
1~5136 . :
compounds were prepared.
.
2 ~ S l SCH2C~2~IC - CH
C~3 -~ . .
Ex. R isolated NoO 1 R2 ~orm physical const. . .
..... _ ... .. _ . . . ~ . .
H hydro- m.p. 169-74a. ~:
chloride (acetone-methanol) 2 CH ~ hydro- m~p. 205-6C. -
3 ~IY chloride (acetone-methanol) .- .
3 ~ H hydro- m,p. 204-5C. . ; ;
W chloride ~ace-tone) : .
3 ~ H hydro- m,p. 204-5C. . ; ;
W chloride ~ace-tone) : .
4 CH H hydro m.p 210-214C l: :
3 chloride (acetone) ~ C~ ree (ben~ene-light 3 base petroleum) ;~:
6 ~- ~ H hydro_ m.p. 180-183C.
chloride (acetone-methanol) . ' , - , ' ;
7 C~30- ~ - H brage nd8 1.5936 8 CH - ~ - H h~dro- m.p. 158--161C. :1 chloride (acetone-methanol) 9 8 H base nd5 1.6162 : ~ , ' ~ ~, '' .
~ hydro- m.p. 150-153C.
~ ~ chloride (acetone-methanol) : ~ .
,' ;' ' ',: ~' ,; , . .. , ,, ;, , ., .,. . . ". .. :, : .. , .. , ., . , :, . ~,.. ,.. ,., ., .. ,, .. ~. .. .. . ... . . .. . .. . .
1~45~36 ., , 11 Br- ~ - H hydro_ m.p. 178-180~.
chloride (acetone-methanol) ':
,~, .
12 ~ _ H base nd9 1.5968 ,. : , . F:" ' ' :
13 NC~ - H hydro_ m.p. 138-143G.
~ chloride (acetone-ethanol) ., . ~ .
. OCH2CH=C~
14 ~ ~ 2 H hydro- m.p. 169-171C
chloride ~acetone-methanol) .:.
:
~ baseee- nd~'5 1.5745 ~ :
.
16 - ~ ~ hydro- m.p. 171-174a chloride (acetone-methanal) ~ .
~1 17 ~ H hydro- . m.p. 176-177C. ~ ;
chloride (aoetone-met~anol) .
18 ~ H hydro- m.p. 140-143~C.
" ~ chloride (acetone-methanol) aH3 -:
ba~e n26 1.5979 ,~ .
~ : : . . ;~ .
: 20 ~ ~ N ~ C~3 H hydro_ m.p. 278-279C
CH3 ~ 5 ~ chloride (methanol-water) ,.
: 21 ~ ~J H free: m.p. 146-147C.
J~ ll base (benæene-light ~" , . -' ~ S ~ \ ~ : petroleum) .~
: . : ~,~ . .. :
. :
. .
........ . . . .
~)4S~3~i 2 D 11 3 "~
l S ~ N OH CX3 S SCH2CHCH2i~C - CH3 3 . :.
No Rl R2 R3 solated ph~sical cons-t. .
22 H H H free base nd6 1.5970 . 23 H X H picrate m.p. 153-154C. .
(chloroform) :; .
24 CH H H h~dro- m.p. 122-124C.
3 chloride (acetone) H H CH3 free base n25 1.6030 : ,... . ..
26 Br CH hydro~ m.p. 176-177C. -k -: -:
3 H chloride (aceto~e_ ; . .
27 CH3 , CH3 ~ h dro- m(apet229-230 C
.:
28 CH3CH2-~ H H chloride (m p l48-149C. ~ ;
29 3, C~ H H hydro- m.pl 145-146C.
: CH3 chlorid~ (chl~roform- . ~ :
methanol) , ,'.
: 30 ~ - H H ~base ~5 lr5966 hy~ro- ~ p D 173-173.5a.
Br H H chloride (acetone-methanol) ~. :
~2 I ~ H H h dro- (aPetone- , 33 CN H H free base ndl 5 1.6009 ~ .
.
~' ' .
~)45~3~
., -.
34 H H CN chloride (acetone-methanol) N02 H H chloride m p 236-237 C.
methanol) 36 H N02 H hydro_ ( P t~7~ 75 C. ;.
- methanol) RC0 ~ ~ ~ , , 3 2 2NH,C - CH3 ..: ,.,:
No R isolated physical const.
37 H2N- ~ree base m-p- 148-149C
. (acetone) 38 CH3NH- hydrochloriae (acpetone2 144 C~
metha~ol) .
39CH3(~H2)3NX- ydrochloride (aPetol06~108 C.
methanol) : ~ m.p. 163-165C
C N- hydrochloride (acet-one-methanol) , . r--~ m.p. 165~166C.
41 ~ N- hydrochloride (acetone-. methanol) :~ :
, . -.:
m.p. 178-179Co 42 0 ~- hydrochloride (acetone-~ methanol) ... -m.p~ 202~207C. ::
43 ~ H2NNH- h~drochloride (acetone- .
: ~ methanol) ~:~
: ~ ' : : '' ' ,` ~ ' '-14- -- ' . !
~ , ' . . ':
''~ , ' '"
'' ' ' , "' .
~04S~36 - ~
(CH3C1~2)2N- hYdrochlOride(aPe.~;l52-l53c. "
methanol). .~
.. ..
r-~ m.p. 140-141C. .:
4~ ~ -NH- free base (ligh-t petro-leum-benzene) 46 ( 3)3C O h~drochloride (aPet25l-252 metha~ol) 47 CH3- free base ~ 5 1.6032 ~ `
48 EtO- h d hl (m p 118-119QC.
49 ~eO- hydrochloride m^p- 124-126~
. . (aceto~e) (.~.
3 chloride (acetone) ~ C~ ree (ben~ene-light 3 base petroleum) ;~:
6 ~- ~ H hydro_ m.p. 180-183C.
chloride (acetone-methanol) . ' , - , ' ;
7 C~30- ~ - H brage nd8 1.5936 8 CH - ~ - H h~dro- m.p. 158--161C. :1 chloride (acetone-methanol) 9 8 H base nd5 1.6162 : ~ , ' ~ ~, '' .
~ hydro- m.p. 150-153C.
~ ~ chloride (acetone-methanol) : ~ .
,' ;' ' ',: ~' ,; , . .. , ,, ;, , ., .,. . . ". .. :, : .. , .. , ., . , :, . ~,.. ,.. ,., ., .. ,, .. ~. .. .. . ... . . .. . .. . .
1~45~36 ., , 11 Br- ~ - H hydro_ m.p. 178-180~.
chloride (acetone-methanol) ':
,~, .
12 ~ _ H base nd9 1.5968 ,. : , . F:" ' ' :
13 NC~ - H hydro_ m.p. 138-143G.
~ chloride (acetone-ethanol) ., . ~ .
. OCH2CH=C~
14 ~ ~ 2 H hydro- m.p. 169-171C
chloride ~acetone-methanol) .:.
:
~ baseee- nd~'5 1.5745 ~ :
.
16 - ~ ~ hydro- m.p. 171-174a chloride (acetone-methanal) ~ .
~1 17 ~ H hydro- . m.p. 176-177C. ~ ;
chloride (aoetone-met~anol) .
18 ~ H hydro- m.p. 140-143~C.
" ~ chloride (acetone-methanol) aH3 -:
ba~e n26 1.5979 ,~ .
~ : : . . ;~ .
: 20 ~ ~ N ~ C~3 H hydro_ m.p. 278-279C
CH3 ~ 5 ~ chloride (methanol-water) ,.
: 21 ~ ~J H free: m.p. 146-147C.
J~ ll base (benæene-light ~" , . -' ~ S ~ \ ~ : petroleum) .~
: . : ~,~ . .. :
. :
. .
........ . . . .
~)4S~3~i 2 D 11 3 "~
l S ~ N OH CX3 S SCH2CHCH2i~C - CH3 3 . :.
No Rl R2 R3 solated ph~sical cons-t. .
22 H H H free base nd6 1.5970 . 23 H X H picrate m.p. 153-154C. .
(chloroform) :; .
24 CH H H h~dro- m.p. 122-124C.
3 chloride (acetone) H H CH3 free base n25 1.6030 : ,... . ..
26 Br CH hydro~ m.p. 176-177C. -k -: -:
3 H chloride (aceto~e_ ; . .
27 CH3 , CH3 ~ h dro- m(apet229-230 C
.:
28 CH3CH2-~ H H chloride (m p l48-149C. ~ ;
29 3, C~ H H hydro- m.pl 145-146C.
: CH3 chlorid~ (chl~roform- . ~ :
methanol) , ,'.
: 30 ~ - H H ~base ~5 lr5966 hy~ro- ~ p D 173-173.5a.
Br H H chloride (acetone-methanol) ~. :
~2 I ~ H H h dro- (aPetone- , 33 CN H H free base ndl 5 1.6009 ~ .
.
~' ' .
~)45~3~
., -.
34 H H CN chloride (acetone-methanol) N02 H H chloride m p 236-237 C.
methanol) 36 H N02 H hydro_ ( P t~7~ 75 C. ;.
- methanol) RC0 ~ ~ ~ , , 3 2 2NH,C - CH3 ..: ,.,:
No R isolated physical const.
37 H2N- ~ree base m-p- 148-149C
. (acetone) 38 CH3NH- hydrochloriae (acpetone2 144 C~
metha~ol) .
39CH3(~H2)3NX- ydrochloride (aPetol06~108 C.
methanol) : ~ m.p. 163-165C
C N- hydrochloride (acet-one-methanol) , . r--~ m.p. 165~166C.
41 ~ N- hydrochloride (acetone-. methanol) :~ :
, . -.:
m.p. 178-179Co 42 0 ~- hydrochloride (acetone-~ methanol) ... -m.p~ 202~207C. ::
43 ~ H2NNH- h~drochloride (acetone- .
: ~ methanol) ~:~
: ~ ' : : '' ' ,` ~ ' '-14- -- ' . !
~ , ' . . ':
''~ , ' '"
'' ' ' , "' .
~04S~36 - ~
(CH3C1~2)2N- hYdrochlOride(aPe.~;l52-l53c. "
methanol). .~
.. ..
r-~ m.p. 140-141C. .:
4~ ~ -NH- free base (ligh-t petro-leum-benzene) 46 ( 3)3C O h~drochloride (aPet25l-252 metha~ol) 47 CH3- free base ~ 5 1.6032 ~ `
48 EtO- h d hl (m p 118-119QC.
49 ~eO- hydrochloride m^p- 124-126~
. . (aceto~e) (.~.
5 CH2=CHCH20- hydrochloride m~p. 135-l36oc~ .
. . (acetone) : 51 . HO- hydrochloride ( P 251)Z5ZC~
Referred hxample :: 2-mercapto-4-(5'.-~itro-2l~thie~yl)-thiazole o a suspension of 1.6 g. of ammonium dithiocarba-mate in 20~ml. of ethanol, 3.0 g. of 2-bromoacetyl-5-nitro- ~.
thiophene was added below~10C.
;; The reaction mixture was stir~ed at room~tempera~
ture overnight,:and then heated under re~lux for 2.5 hours, :.:
followed b~evaporation in vacuo.
o~the~resldue, dilute aqueous ammonia was added, and~the filtrate was acidified with dilute aqueous hydro- ;.,:. '..
; ~ . . .
: chloric acid solu-tion.
he precipita-te was collected and .recr~stallized .;~
from acetone-methanol t~o give 2.8 g. of ~-mercapto-4-(5'- ; .
. . .
..
~045~36 :' ' nitro-2'-thietnyl)-thiazole; needles, m.p. 214C.
~ouna: c, 34.27; H, 1.59; I~, 11.50; S, 39.10 (%).
C7H902N2~3 requires C, 34.43; H, 1.64; N, 11.48; S~
39~34 (%)-Accordin~ to the method of Re~erred EXample 1, the following compou~ds were prepared.
Rb~lrRc '`1 Ra - S S:EI: . ' ,' Re~rd.
Ex m.pO sol~e~t No. Ra RbRc (C-) tfllizrY~ Y(yO) tion `
: 2 ~:X2NC0- ,- iH H 259 methanol 87 .-:
3 CN H H 225-6 aethan0el 91.7 4 H N02 ~ E 211-2 ~cxcha~l~ 97 : 5 ~ H3CCo_` H acetone- 60 ~
. . - . ether :.
. . (acetone) : 51 . HO- hydrochloride ( P 251)Z5ZC~
Referred hxample :: 2-mercapto-4-(5'.-~itro-2l~thie~yl)-thiazole o a suspension of 1.6 g. of ammonium dithiocarba-mate in 20~ml. of ethanol, 3.0 g. of 2-bromoacetyl-5-nitro- ~.
thiophene was added below~10C.
;; The reaction mixture was stir~ed at room~tempera~
ture overnight,:and then heated under re~lux for 2.5 hours, :.:
followed b~evaporation in vacuo.
o~the~resldue, dilute aqueous ammonia was added, and~the filtrate was acidified with dilute aqueous hydro- ;.,:. '..
; ~ . . .
: chloric acid solu-tion.
he precipita-te was collected and .recr~stallized .;~
from acetone-methanol t~o give 2.8 g. of ~-mercapto-4-(5'- ; .
. . .
..
~045~36 :' ' nitro-2'-thietnyl)-thiazole; needles, m.p. 214C.
~ouna: c, 34.27; H, 1.59; I~, 11.50; S, 39.10 (%).
C7H902N2~3 requires C, 34.43; H, 1.64; N, 11.48; S~
39~34 (%)-Accordin~ to the method of Re~erred EXample 1, the following compou~ds were prepared.
Rb~lrRc '`1 Ra - S S:EI: . ' ,' Re~rd.
Ex m.pO sol~e~t No. Ra RbRc (C-) tfllizrY~ Y(yO) tion `
: 2 ~:X2NC0- ,- iH H 259 methanol 87 .-:
3 CN H H 225-6 aethan0el 91.7 4 H N02 ~ E 211-2 ~cxcha~l~ 97 : 5 ~ H3CCo_` H acetone- 60 ~
. . - . ether :.
6 ~ t2~cc- ~ H H 1~9-90 ~Ct1ne 81 '
7 t-BuNEC0- H H~ 227-8 acetone 79 . ;
H2~HCC- ~ H~ ~ 282-3 methano1 84 9 ~ NCC- H H 211-3 acetone 83 ;:~ ~ NC0- ~ H ~ H ~212-3 acetone 80 ~: ~ . . , : . i : . ' - .
: ::
~)45~31~
., . - ~ :
11 ~ NC0- H H 141-2 0Hctone- 77 12CH~NHC0 H H 253-4 methanol 82 .
13 n-~uNHC0- H ~-I 157-8 petroleum 64.4 . ether 14 ~ -NHC0- H H 235-6 actetone B3.6 3 H H 219_20 benzene- 78O5 ~ (:
. . :. , .
16t-BuOOC- H H 182-3 ethanol 89.1 17t-BuOOCCH2NHC0 H H 180-1 acetone 87 . .
. ,. ~ ... .
. . acetone-18 H CN H 195-6 petroleum 65 ~
benzine ~.
.19CH3CONH H H 300 ethanol 83.3 . .
20 ~: ~ C~ CN 207-8 ethanol 70 Referred Example 21 :' . .
~ 2-mercapto-4-(2'-N-methylp~xrolyl)-thiazole ... ...
~ o a suspension of 5.8 g. of ammonium dithio- :.
: ~ .
carbamate in 50 m:L. of absolute ethanol, 7.6 g. of 2- ..
chloroacetyl-N-methylpyrrol ~as added below 20C. ~he ", .:
reaction~mixture was stirred at room temperature and heated under reflux ~or 2 hours, followed by evaporation in ~acuo. .
The residue was treated with 100 ml. of water, :~ ~
: precipltated product was collected and recrystalli~ed from . .-::
ethanol to yield 6.8 g. of 2-mercapto-4-(2'-N-methylpyrxol)-~ ~
j,~, .:
~ thiazole; white solid, m.p. 110 ~ 111.5C~
.:: .
. -~ . , ~ . ' ''"''.
. . .
~L0~5~L36 ..
Found: C, 48,75; H, 4.01; N, 14.60; S, 32.61 (~
C8H8N2S2 requlres C, 48.98; H, ~.08; N, 14.29; S, 32.65 (%).
Re~erred Example_ 22 2-mercapto-4-(5'-carboxy-2'-thienyl)-thiazole A solution of 1.5 g. of 2-mercapto-4~(5'-t-buto-xycarbonyl-2'-thieny1)-thiazole in 5 % ethanolic hydrochloric acid was refluxed for 1 hour.
After cooling, the solution was evaporated to -~ . - ..
dr~ess. ~he residue was washed with water and recrystal-lized from methanol to yield 1.2 g. of 2-mercapto-4-(5'-carboxy-2'-thienyl)-thiazole;~Yhite solid, m.p. 249-250C.
Found: C, 39.65; H, 2.01; N, 5.70; S, 39.95 (%).
C8E502NS3 re~uires C, 39.51; H, 2.06; N, 5.76; S~ 39.51 (%).
:
Re erred Exemple _3 According to the Referred Example 22, 2-mercapto~
4-(5'-carboxymeth~laminocarbon~1-2'-thienyl)-thiazole; ~ -- - m.p. 153-155C. (recrystalli~æed from acetone) was pre-pared~from 2-mercapto-4-(5'-t-butoxycarbo~ylmethylamino~
carbonJ1-2'-thienyl)-thiazole.~
Re~erred Example~ 24 o the solution of 1.2 g. o~ sodium dithiocar-~- -bamate 1n 20~ ml. oP mixture of ~7ater and ethanol (1 ~2~.3 g.~ o~5-c~ano-2-bromoacet~1 thiophene was added por- -~
tionwise.~
The react1on mixbure was~stirred at room tempera- ;
;~ ~ ture~overnight~, heated at 60C~ for 2 hours and cooled.
fter a~ld1fication, the~precipltates were collected~
~dried~and~recrystallized from mixed sol~ent o~ acetone 18~-45~3~ -...,..., .. ~ ,...
, .,:~!
and metha~ol to yield 1.9 g. of 2-mercapto-4-(5'-cyano-2'-thienyl)-thiazole; pale yellow powder, m.p. 225-226C.
~ ound: C, 42.17; H, 1.90; N, 12.56; S, 42.50 (%).
C~X4N2S3 requires C, 42.86; H, 1.79; N, 12.50; S, 42.86 (%).
Re~erred Example 25 A solution of 57.6 g. o~ 2-mercapto-4-~5'-cyano-2'-thienyl)-thiazole in an aqueous alkaline solution, pre-pared ~rom 20.4 g. of sodium hydroxide and 1.4 liters of water, was stood at room temperature overnight.
~ he solution was acidi~ied with hydrochloric acid, and precipitate was recr~stallization ~rom methanol to yield 52.7 g. o~ 2-mercapto-4-(5'-carbamo~1-2'-thienyl)-thiazole; pale yellow needles9 m.p. 259C.
. . .
~ .,:, . . .
"~ :'.:.' : .
., ,i .. .
:. '~. .
. .: !
' i ' -; ' ' ,, ,'~ ,'.,"'" '; ~
:~ ' '; ,' ''''' ~ ' ' ", . . ' :, :.
i: ': '::
- , ', '. ~ ' ~'' '~' "' ''' : ~ ' , ~ " ' ;':
: ' . ' '." '' . ' :~ ~ ' ` . . ' ' ',:
';
, , - 19 ~ , ':' ' : .
'~
~)45136 Example 52. 2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5/-carbamoyl-2'-thienyl)thiazole A solution of 2-(3'-chloro-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole,4.0g(0.012 mol) and t-butylamine 70 g(large excess) was heated at 100 D in a sealed tube for 3 hrs. After cooling, t-butylamine was removed and residue was treated with methanolic hydrochloric acid solution.
Recrystallization of the crude hydrochloride from methanol provided 4.55g(93 %) of 2-(3'-t-butylamino-2'-hydroxypropylthio) -4-(5--carbamoyl-2'-thienyl)thiazole hydrochloride,mp 234-235.5, which was identified with the hydrochloride of the compound ~n Example 37 (i.r., n.m.r. and mixed melting point determination).
' ': . ::
2-(3'-chloro-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole employed as the starting material was prepared by the following method described below.
2-Mercapto4-(5'-carbamoyl-2'-thienyl)thiazole, 12.lg (0.05 mol) was dissolved in an aqueous sodium hydroxide(2.2g= ` -0.055 mol) soIution(200 ml) and stirred with 5.0 g(0.054 mol) -~
Of epichlorohydrin at room temperature for 2.5 hrs. The visid product separated from the reaction solution was taken out -by decantation, dissolved in ethyl acetate, washed with an 10 %
~sodium hydroxlde solution, dried and evaporated.~ Column chro-matography of this residue(15.5g) on silica gel(200g) was carried out. Eluate with acetone-chloroform(1-5) provided 2-(3'-chloro-2'-hydroxypropylthio)-4-(5'-càrbamoyl-2'-thienyl)thiazole,m.p. ;
143-5~(recrystallized from methanol).
Found: C,44.I2; H,3.60; N,9.41; 5,32.15(~) Cl1HloN2O2S3 requires C,44.30; H,3.36; N,9.40; S,32~21(%).
: :, :.
~ ` - 20 1C)45136 Example 53. 2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-methyl-2'-thienyl)thiazole hydrochloride To a solution of 2-mercapto-4-(5'-methyl-2'-thienyl)thiazole
H2~HCC- ~ H~ ~ 282-3 methano1 84 9 ~ NCC- H H 211-3 acetone 83 ;:~ ~ NC0- ~ H ~ H ~212-3 acetone 80 ~: ~ . . , : . i : . ' - .
: ::
~)45~31~
., . - ~ :
11 ~ NC0- H H 141-2 0Hctone- 77 12CH~NHC0 H H 253-4 methanol 82 .
13 n-~uNHC0- H ~-I 157-8 petroleum 64.4 . ether 14 ~ -NHC0- H H 235-6 actetone B3.6 3 H H 219_20 benzene- 78O5 ~ (:
. . :. , .
16t-BuOOC- H H 182-3 ethanol 89.1 17t-BuOOCCH2NHC0 H H 180-1 acetone 87 . .
. ,. ~ ... .
. . acetone-18 H CN H 195-6 petroleum 65 ~
benzine ~.
.19CH3CONH H H 300 ethanol 83.3 . .
20 ~: ~ C~ CN 207-8 ethanol 70 Referred Example 21 :' . .
~ 2-mercapto-4-(2'-N-methylp~xrolyl)-thiazole ... ...
~ o a suspension of 5.8 g. of ammonium dithio- :.
: ~ .
carbamate in 50 m:L. of absolute ethanol, 7.6 g. of 2- ..
chloroacetyl-N-methylpyrrol ~as added below 20C. ~he ", .:
reaction~mixture was stirred at room temperature and heated under reflux ~or 2 hours, followed by evaporation in ~acuo. .
The residue was treated with 100 ml. of water, :~ ~
: precipltated product was collected and recrystalli~ed from . .-::
ethanol to yield 6.8 g. of 2-mercapto-4-(2'-N-methylpyrxol)-~ ~
j,~, .:
~ thiazole; white solid, m.p. 110 ~ 111.5C~
.:: .
. -~ . , ~ . ' ''"''.
. . .
~L0~5~L36 ..
Found: C, 48,75; H, 4.01; N, 14.60; S, 32.61 (~
C8H8N2S2 requlres C, 48.98; H, ~.08; N, 14.29; S, 32.65 (%).
Re~erred Example_ 22 2-mercapto-4-(5'-carboxy-2'-thienyl)-thiazole A solution of 1.5 g. of 2-mercapto-4~(5'-t-buto-xycarbonyl-2'-thieny1)-thiazole in 5 % ethanolic hydrochloric acid was refluxed for 1 hour.
After cooling, the solution was evaporated to -~ . - ..
dr~ess. ~he residue was washed with water and recrystal-lized from methanol to yield 1.2 g. of 2-mercapto-4-(5'-carboxy-2'-thienyl)-thiazole;~Yhite solid, m.p. 249-250C.
Found: C, 39.65; H, 2.01; N, 5.70; S, 39.95 (%).
C8E502NS3 re~uires C, 39.51; H, 2.06; N, 5.76; S~ 39.51 (%).
:
Re erred Exemple _3 According to the Referred Example 22, 2-mercapto~
4-(5'-carboxymeth~laminocarbon~1-2'-thienyl)-thiazole; ~ -- - m.p. 153-155C. (recrystalli~æed from acetone) was pre-pared~from 2-mercapto-4-(5'-t-butoxycarbo~ylmethylamino~
carbonJ1-2'-thienyl)-thiazole.~
Re~erred Example~ 24 o the solution of 1.2 g. o~ sodium dithiocar-~- -bamate 1n 20~ ml. oP mixture of ~7ater and ethanol (1 ~2~.3 g.~ o~5-c~ano-2-bromoacet~1 thiophene was added por- -~
tionwise.~
The react1on mixbure was~stirred at room tempera- ;
;~ ~ ture~overnight~, heated at 60C~ for 2 hours and cooled.
fter a~ld1fication, the~precipltates were collected~
~dried~and~recrystallized from mixed sol~ent o~ acetone 18~-45~3~ -...,..., .. ~ ,...
, .,:~!
and metha~ol to yield 1.9 g. of 2-mercapto-4-(5'-cyano-2'-thienyl)-thiazole; pale yellow powder, m.p. 225-226C.
~ ound: C, 42.17; H, 1.90; N, 12.56; S, 42.50 (%).
C~X4N2S3 requires C, 42.86; H, 1.79; N, 12.50; S, 42.86 (%).
Re~erred Example 25 A solution of 57.6 g. o~ 2-mercapto-4-~5'-cyano-2'-thienyl)-thiazole in an aqueous alkaline solution, pre-pared ~rom 20.4 g. of sodium hydroxide and 1.4 liters of water, was stood at room temperature overnight.
~ he solution was acidi~ied with hydrochloric acid, and precipitate was recr~stallization ~rom methanol to yield 52.7 g. o~ 2-mercapto-4-(5'-carbamo~1-2'-thienyl)-thiazole; pale yellow needles9 m.p. 259C.
. . .
~ .,:, . . .
"~ :'.:.' : .
., ,i .. .
:. '~. .
. .: !
' i ' -; ' ' ,, ,'~ ,'.,"'" '; ~
:~ ' '; ,' ''''' ~ ' ' ", . . ' :, :.
i: ': '::
- , ', '. ~ ' ~'' '~' "' ''' : ~ ' , ~ " ' ;':
: ' . ' '." '' . ' :~ ~ ' ` . . ' ' ',:
';
, , - 19 ~ , ':' ' : .
'~
~)45136 Example 52. 2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5/-carbamoyl-2'-thienyl)thiazole A solution of 2-(3'-chloro-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole,4.0g(0.012 mol) and t-butylamine 70 g(large excess) was heated at 100 D in a sealed tube for 3 hrs. After cooling, t-butylamine was removed and residue was treated with methanolic hydrochloric acid solution.
Recrystallization of the crude hydrochloride from methanol provided 4.55g(93 %) of 2-(3'-t-butylamino-2'-hydroxypropylthio) -4-(5--carbamoyl-2'-thienyl)thiazole hydrochloride,mp 234-235.5, which was identified with the hydrochloride of the compound ~n Example 37 (i.r., n.m.r. and mixed melting point determination).
' ': . ::
2-(3'-chloro-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl)thiazole employed as the starting material was prepared by the following method described below.
2-Mercapto4-(5'-carbamoyl-2'-thienyl)thiazole, 12.lg (0.05 mol) was dissolved in an aqueous sodium hydroxide(2.2g= ` -0.055 mol) soIution(200 ml) and stirred with 5.0 g(0.054 mol) -~
Of epichlorohydrin at room temperature for 2.5 hrs. The visid product separated from the reaction solution was taken out -by decantation, dissolved in ethyl acetate, washed with an 10 %
~sodium hydroxlde solution, dried and evaporated.~ Column chro-matography of this residue(15.5g) on silica gel(200g) was carried out. Eluate with acetone-chloroform(1-5) provided 2-(3'-chloro-2'-hydroxypropylthio)-4-(5'-càrbamoyl-2'-thienyl)thiazole,m.p. ;
143-5~(recrystallized from methanol).
Found: C,44.I2; H,3.60; N,9.41; 5,32.15(~) Cl1HloN2O2S3 requires C,44.30; H,3.36; N,9.40; S,32~21(%).
: :, :.
~ ` - 20 1C)45136 Example 53. 2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-methyl-2'-thienyl)thiazole hydrochloride To a solution of 2-mercapto-4-(5'-methyl-2'-thienyl)thiazole
8.lg(0.038 mol) in an aqueous sodium hydroxide solution prepared from sodium hydroxide,3.5g(0.088 mol) and 100 ml of water,was added 4.22 g(0.0456 mol) of epichlorohydrin in one potion at room temperature. The resulting solution was allowed to stand at room temperature for 3 hrs, ahd extracted with methylene chloride. The organic phase was dried and evaporated in vacuo.
The residue , without purification, and 30 g(large excess) of `
t-butylamine were heated at 70 for 3 hrs. Excess t-butylamine , was removed and residue was dissolved in 100 ml of methylene - ;
chloride followed by treatment with dry HCl gas. Precipitate was collected and recrystallized from acetone to yield 2-(3'- `
t-butylamino-2'-hydroxypropylthio)-4-(5'-methyl-2'-thienyl) thiazole hydrochloride, mp 123-5 , which was identified with the compound on Experiment 24. (i.r., n.m.r., and mixed meltin~
point determination) ~;
According to the method of Example 2, all compounds listed in the ~able (Ex. No.1-50) are also prepared : ; :
.
- ..
- 21 - ~
~, - :' :~ ' ~ ~ ' . ...... , ....... ... ... ~ ~ - - ~
The residue , without purification, and 30 g(large excess) of `
t-butylamine were heated at 70 for 3 hrs. Excess t-butylamine , was removed and residue was dissolved in 100 ml of methylene - ;
chloride followed by treatment with dry HCl gas. Precipitate was collected and recrystallized from acetone to yield 2-(3'- `
t-butylamino-2'-hydroxypropylthio)-4-(5'-methyl-2'-thienyl) thiazole hydrochloride, mp 123-5 , which was identified with the compound on Experiment 24. (i.r., n.m.r., and mixed meltin~
point determination) ~;
According to the method of Example 2, all compounds listed in the ~able (Ex. No.1-50) are also prepared : ; :
.
- ..
- 21 - ~
~, - :' :~ ' ~ ~ ' . ...... , ....... ... ... ~ ~ - - ~
Claims (14)
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A process for producing thiazole derivatives of the formula (I) (I) wherein R1 is hydrogen, lower alkyl, C3-C6 cycloalkyl, aryl or heteroaromatic ring, said aryl being selected from the group consisting of phenyl and naphthyl each of which may optionally be substituted with C1-C4 alkyl, C1-4 alkoxy, C3-C5 alkenoxy, halogen or cyano, said heteroaromatic ring being selected from the group consisting of thienyl, furyl, pyridyl, pyrrolyl, thiazolyl, and benzothiazolyl each of which may optionally be substituted with lower alkyl, halogen, cyano, phenyl, C2-C8 acylamino, a group of the formula, [wherein Y is hydroxy, lower alkyl, lower alkoxy or lower alkenyloxy], or a group of the formula [wherein R5 and R6 are each hydrogen, amino, lower alkyl, C3-C6 cycloalkyl, or R5 and R6 may form a morpholino piperidino, or pyrrolydino group], R2 is hydrogen, lower alkyl, phenyl, or lower alkyl-substituted phenyl, R3 is hydrogen and R4 is t-butyl which comprises reacting thiazole ?ivatives of the formula (II) (II) wherein R1 and R2 have the same meanings as defined above, and A is or and X is halogen with an amine of the formula (III) HNR3R4 (III) wherein R3 and R4 have the same meanings as defined above.
2. A process for producing thiazole derivatives of the formula (I) (I) wherein R1, R2, R3 and R4 have the same meanings as defined above which comprises reacting halohydrin derivatives of the formula (IIa) (IIa) wherein X is halogen, with an amine of the formula (III) HNR3R4 (III) wherein R3 and R4 have the same meanings as defined above.
3. A process according to claim 1, wherein the reaction is carried out by heating within a temperature range of from 30°C.
to 150°C.
to 150°C.
4. A process according to claim 1, wherein the reaction is carried out in the presence of an organic solvent.
5. A process according to claim 1, wherein the reaction is carried out by heating under reflux in an alcoholic solution
6. A process according to claim 1, wherein the reaction is carried out in a nitrogen gas atmosphere.
7. A process according to claim 1 wherein R1 is hydrogen, lower alkyl, C3-C6 cycloalkyl, phenyl, naphthyl, phenyl which is substituted with lower alkyl, lower alkoxy, halogen, cyano, hydroxy or C3-C5 lower alkenyloxy, R2 and R3 are hydrogen and R4 is t-butyl.
8. A process according to claim 1 wherein R1 is thienyl or substituted thienyl having one or more substituents selected from lower alkyl, halogen, cyano, nitro, phenyl, a group of the formula [in which R5 is hydrogen or lower alkyl, and R6 is hydrogen, lower alkyl, amino, or C3-C6 cycloalkyl.], or a group of the formula [in which Y is hydroxy, lower alkoxy, lower alkyl or C3-C5 alkenyloxy.] R2 and R3 are hydrogen and R4 is t-butyl.
9. A process according to claim 1 wherein R1 is furyl, pyridyl, pyrrolyl, thiazole, or benzothiazolyl, each of which may optionally be substituted with lower alkyl, R2 and R3 are hydrogen and R4 is t-butyl.
10. A process according to claim 1 for producing a thiazole derivative of the formula wherein R1 is R2 is hydrogen, R3 is hydrogen and R4 is t-butyl.
11. A process according to claim 1 for producing a thiazole derivative of the formula wherein R1 is R2 is hydrogen, R3 is hydrogen and R4 is t-butyl.
12. A process according to claim 1 for producing a thiazole derivative of the formula wherein R1 is R2 is hydrogen, R3 is hydrogen and R4 is t-butyl.
13. A process according to claim 1 for producing a thiazole derivative of the formula wherein R1 is R2 is hydrogen, R3 is hydrogen and R4 is t-butyl.
14. A process according to claim 1 for producing a thiazole derivative of the formula wherein: R1 is R2 is hydrogen, R3 is hydrogen and R4 is t-butyl.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12607073A JPS5239827B2 (en) | 1973-11-08 | 1973-11-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1045136A true CA1045136A (en) | 1978-12-26 |
Family
ID=14925858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA213,282A Expired CA1045136A (en) | 1973-11-08 | 1974-11-07 | Thiazole derivatives |
Country Status (5)
Country | Link |
---|---|
JP (1) | JPS5239827B2 (en) |
CA (1) | CA1045136A (en) |
CH (1) | CH605867A5 (en) |
HU (1) | HU168452B (en) |
NL (1) | NL7414537A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7514566B2 (en) | 2006-01-18 | 2009-04-07 | Amgen, Inc. | Thiazole compounds and methods of use |
US7897619B2 (en) | 2007-07-17 | 2011-03-01 | Amgen Inc. | Heterocyclic modulators of PKB |
US7919504B2 (en) | 2007-07-17 | 2011-04-05 | Amgen Inc. | Thiadiazole modulators of PKB |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8302591D0 (en) * | 1983-01-31 | 1983-03-02 | Fujisawa Pharmaceutical Co | Thiazole derivatives |
-
1973
- 1973-11-08 JP JP12607073A patent/JPS5239827B2/ja not_active Expired
-
1974
- 1974-11-06 HU HUSU000879 patent/HU168452B/hu unknown
- 1974-11-07 CA CA213,282A patent/CA1045136A/en not_active Expired
- 1974-11-07 NL NL7414537A patent/NL7414537A/en not_active Application Discontinuation
- 1974-11-07 CH CH1490074A patent/CH605867A5/en not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7514566B2 (en) | 2006-01-18 | 2009-04-07 | Amgen, Inc. | Thiazole compounds and methods of use |
US8084479B2 (en) | 2006-01-18 | 2011-12-27 | Amgen Inc. | Thiazole compounds and methods of use |
US7897619B2 (en) | 2007-07-17 | 2011-03-01 | Amgen Inc. | Heterocyclic modulators of PKB |
US7919504B2 (en) | 2007-07-17 | 2011-04-05 | Amgen Inc. | Thiadiazole modulators of PKB |
Also Published As
Publication number | Publication date |
---|---|
JPS5239827B2 (en) | 1977-10-07 |
CH605867A5 (en) | 1978-10-13 |
HU168452B (en) | 1976-04-28 |
NL7414537A (en) | 1975-05-12 |
JPS5076069A (en) | 1975-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3055907A (en) | Acyl benzimidazoles and method of preparing same | |
KR100222309B1 (en) | Substituted 2-acylamino-5-thiazole, their preparation and pharmaceutical composition containing them | |
AU593640B2 (en) | Thienopyrimidine-2,4-dione derivatives | |
AU627203B2 (en) | Ethylenediamine monoamide derivatives | |
CH651300A5 (en) | HETEROCYCLICALLY SUBSTITUTED AMINOPROPENNITRILE. | |
Xie et al. | New efficient synthesis of trisubstituted imidazolidine-2-thiones and thiazoles via vinyliminophosphoranes | |
NZ202471A (en) | Heterocyclic derivatives and pharmaceutical compositions having cardiotonic and/or antihypertensive properties | |
Sugimoto et al. | Activation of dithiocarbamate by 2-halothiazolium salts | |
GB2071663A (en) | 2-amino-1,3,4-thiadiazole derivatives of use as dyestuff intermediates | |
CA1045136A (en) | Thiazole derivatives | |
NO125931B (en) | ||
PL125628B1 (en) | Fungicidal and plant growth regulating agent and process for manufacturing novel 1-thia-3-aza-4-ones | |
US2623048A (en) | 4-thiazolidone derivatives and process for preparing the same | |
US3476766A (en) | Certain 2,4 - diarylthiazole-5-alkanoic acids and derivatives thereof | |
US3236855A (en) | Certain n-phenyl(thiazole-hydroxamidine) compounds and their preparation | |
CA1246086A (en) | Iminothiazolidine derivatives | |
Sayed et al. | A facile one‐pot synthesis of thiazo [2′, 3′: 2, 1] imidazo [4, 5‐b] pyrane; thiazo [2′, 3′: 2, 1] imidazo [4, 5, b] pyridine; imidazo [2, 1‐b] thiazole and 2‐(2‐amino‐4‐methylthiazol‐5‐yl)‐1‐bromo‐1, 2‐ethanedione‐1‐arylhydrazones | |
Abdel-Aziz et al. | Synthesis and anti-arrhythmic activity of some piperidine-based 1, 3-thiazole, 1, 3, 4-thiadiazole, and 1, 3-thiazolo [2, 3-c]-1, 2, 4-triazole derivatives | |
Gülten et al. | Fast and Efficient One-Pot Three-Component Synthesis of Some 1, 2, 3, 4-Tetrahydro-6-methyl-N-phenyl-5-pyrimidinecarboxamide Derivatives via Biginelli Condensation Reaction | |
CA1111034A (en) | Azathianaphthalene derivatives, process for their manufacture, pharmaceutical preparations containing them and their use | |
US4344946A (en) | 2,6-Diamino-benzo[1,2-d:5,4-d']bisthiazoles and salts thereof | |
US3705903A (en) | 2-carbamido and thiocarbamido oxazoles | |
US3637725A (en) | Certain 5-nitro-4-thiazolin-2-ylideneurea compounds | |
Fathalla et al. | Convenient domino synthesis of quinazolin-4 (3H)-ylidene carbothioamides and carbamothioates | |
US2780628A (en) | 2-substituted aromatic thiazoles |